RNS Number : 2853F
Byotrol PLC
13 November 2020
Byotrol plc
("Byotrol" or the "Group")
Result of Annual General Meeting ("AGM")
Byotrol plc (AIM: BYOT), the anti-microbial technology company, announces that all resolutions proposed at the AGM held earlier today, as set out in the Notice of Annual General Meeting dated 20 October 2020, were duly passed.
The total proxy votes cast prior to the AGM were as follows:
Resolution
In favour
Against
Withheld*
Votes
%
Votes
%
Votes
1
78,569,641
99.95
33,300
0.04
5,240,263
2
78,563,620
99.94
39,321
0.05
5,240,263
3
78,563,620
99.94
39,321
0.05
5,240,263
4
83,682,865
99.98
6,771
0.01
153,568
5
83,642,644
99.87
97,278
0.12
103,282
6
83,642,644
99.87
97,278
0.12
103,282
7
83,546,310
99.87
97,278
0.12
199,616
*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "in favour" or "against" the resolutions.
In line with the instructions provided in the Notice and in accordance with the current coronavirus rules implemented by the UK Government, David Traynor and Nic Hellyer, each of whom is a shareholder and/or proxy appointed by one or more shareholders of the Company, formed the quorum for the AGM and were the only persons present throughout. Mr Traynor chaired the AGM. All recommended social distancing precautions were observed by Mr Traynor and Mr Hellyer and the duration of the AGM was minimised in accordance with current Government rules.
Directorate Change
The Directors also now confirm the formal retirement of Dr Till Medinger from the Board of Byotrol, with thanks for his exceptional service over the past 11 years and sincere best wishes for the future.
For further information contact:
Byotrol Plc
David Traynor, Chief Executive
+44 (0)1925 742 000
Nic Hellyer, CFO
finnCap Limited (Nominated adviser and broker)
+44 (0)20 7220 0500
Geoff Nash/Kate Bannatyne - Corporate Finance
Richard Chambers - ECM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGFLFFLLALVLII
